Pacliarc 30 mg Injection 5 ml Substitute
RXMylan Pharmaceuticals Pvt Ltd
₹1035
(₹186.3/ 1ml)
RXUnited Biotech Pvt Ltd
₹1081.5
(₹190.34/ 1ml)
RXCytogen
₹1085
(₹195.3/ 1ml)
RXAlkem Laboratories Ltd
₹1131
(₹203.58/ 1ml)
RXZydus Healthcare Ltd
₹1131
(₹203.58/ 1ml)
RXAdmac Pharma Ltd
₹1131
(₹203.58/ 1ml)
RXEsperer Bio Research Pvt Ltd
₹1140
(₹205.2/ 1ml)
RXAlkem Laboratories Ltd
₹1154
(₹207.72/ 1ml)
RXLupin Ltd
₹1206
(₹217.08/ 1ml)
RXGetwell Oncology Pvt Ltd
₹1206
(₹217.08/ 1ml)
RXEmcure Pharmaceuticals Ltd
₹1278.5
(₹230.13/ 1ml)
RXGLS Pharma Ltd
₹1575
(₹283.5/ 1ml)
RXKhandelwal Laboratories Pvt Ltd
₹481.8
(₹433.62/ 1ml)
RXBhardwaj India Pvt Ltd
₹1050
(₹1050.0 per unit)
RXIntas Pharmaceuticals Ltd
₹3093.5
(₹2722.3 per unit)

Composition:
PACLITAXEL-30MG
Uses:
Ovarian cancer, breast cancer, non-small cell lung cancer.
Medicinal Benefits:
Pacliarc 30 mg Injection 5 ml belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Pacliarc 30 mg Injection 5 ml may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Pacliarc 30 mg Injection 5 ml contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.
Pacliarc 30 mg Injection 5 ml works by stopping cell division and preventing the growth of certain cancer cells.
Pacliarc 30 mg Injection 5 ml might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.
The most common side effect of Pacliarc 30 mg Injection 5 ml is hair loss. The hair may grow back after the treatment with Pacliarc 30 mg Injection 5 ml is finished. However, consult your doctor if you have any concerns.